Table 1 from Blood-Based Genomic Alteration Signature for Predicting Progression-Free Survival in De Novo Metastatic Hormone-Sensitive Prostate Cancer: A Real-World Study
收藏数据链接：
官方服务：
资源简介：
Clinical characteristics at diagnosis with mHSPC.
创建时间：
2025-12-01
